Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:34 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | Lundbeckfond Invest A/S | 1,835,959 6.900% | 1,835,959 (New Position) | View |
| 2023-08-14 3:45 pm Purchase | 13D | IO BIOTECH INC IOBT | Lundbeckfond Invest A/S | 21,851,920 29.600% | 15,802,468 (+261.22%) | View |
| 2022-01-26 4:15 pm Unchanged | 13G | TREVI THERAPEUTICS INC TRVI | Lundbeckfond Invest A/S | 1,151,544 4.500% | 0 (Unchanged) | View |
| 2022-01-26 4:10 pm Purchase | 13G | OnKure Therapeutics Inc. OKUR | Lundbeckfond Invest A/S | 2,031,224 8.300% | 2,031,224 (New Position) | View |
| 2022-01-26 4:06 pm Purchase | 13G | Aura Biosciences Inc. AURA | Lundbeckfond Invest A/S | 2,017,652 6.900% | 2,017,652 (New Position) | View |
| 2021-11-19 4:15 pm Purchase | 13D | IO BIOTECH INC IOBT | Lundbeckfond Invest A/S | 6,049,452 21.800% | 6,049,452 (New Position) | View |
| 2021-02-03 4:31 pm Purchase | 13G | Enliven Therapeutics Inc. ELVN | Lundbeckfond Invest A/S | 1,432,722 8.200% | 1,432,722 (New Position) | View |
| 2020-01-31 4:20 pm Sale | 13G | SPERO THERAPEUTICS INC SPRO | Lundbeckfond Invest A/S | 877,489 4.600% | -214,285 (-19.63%) | View |
| 2020-01-31 4:19 pm Purchase | 13G | TREVI THERAPEUTICS INC TRVI | Lundbeckfond Invest A/S | 1,151,544 6.500% | 1,151,544 (New Position) | View |